Skip to Content

Glycemic Control in Type 1 Diabetes Improved During Lockdown

WEDNESDAY, Dec. 30, 2020 -- On average, glycemic control improved during lockdown among people living with type 1 diabetes, according to a study published online Dec. 23 in Diabetes Care.

Louis Potier, M.D., from Bichat Hospital in Paris, and colleagues conducted an observational assessment from a self-reported questionnaire on behavioral changes and glycemic information from flash glucose monitoring (FGM) during lockdown in 1,378 individuals living with type 1 diabetes. Change in the mean glucose level two months before and one month after the lockdown was the main outcome.

The researchers observed improvement in mean glucose from 9.1 ± 1.7 mmol/L to 8.7 ± 1.7 mmol/L. Decreased alcohol consumption, an increase in the frequency of FGM scans and in the number of hypoglycemic events, and an easier diabetes control perception were factors associated with better glycemic control (odds ratios, 1.75, 1.48, 1.67, and 1.71, respectively).

"Our study suggests that while the lockdown was a source of anxiety for many people with type 1 diabetes, it was also an opportunity to make positive behavioral changes," the authors write. "Their persistence after easing of lockdown should be studied."

Several authors disclosed financial ties to the biopharmaceutical and medical device industries.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

DKA Common in Blacks With T1DM and Confirmed COVID-19

WEDNESDAY, Jan. 13, 2021 -- Non-Hispanic Blacks with type 1 diabetes (T1D) and confirmed COVID-19 are more likely than non-Hispanic Whites to present with diabetic ketoacidosis...

Hyperglycemia, Hypoglycemia Linked to Poor Outcomes in COVID-19

WEDNESDAY, Dec. 16, 2020 -- For patients with COVID-19, hyperglycemia and hypoglycemia are associated with poor outcomes, according to a study published online Dec. 15 in Diabetes...

Risk of Severe COVID-19 Up Among Those With Diabetes

MONDAY, Dec. 14, 2020 -- Both type 1 and type 2 diabetes independently increase the adverse impacts of COVID-19, according to a study published online Dec. 2 in Diabetes...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.